ImmunoBiome, Inc.

ImmunoBiome, Inc. is a South Korean biotechnology company headquartered in Nam-gu, South Korea. According to its official website, the company develops microbiome-targeted therapeutics for intractable immune diseases, including cancer and autoimmune diseases. Its work is based on world-class foundational research in the microbiome field. The company presents itself as a developer of treatments for difficult-to-treat conditions, positioning its science at the intersection of microbiome research and immunology. Its website highlights company introduction, research achievements, core technology, and talent recruitment sections, indicating an active research and development organization. The company is registered as a business entity in South Korea and is associated with Nam-gu. No public information is available in the provided evidence regarding its founding year, founders, ownership structure, or specific product pipeline. As a microbiome therapeutics developer, ImmunoBiome operates in the biotechnology sector, focusing on translating microbiome science into therapies for immune-related diseases.

ImmunoBiome, Inc. is a South Korean biotechnology company based in Nam-gu, South Korea. The company focuses on the development of microbiome-targeted therapeutics for intractable immune diseases, including cancer and autoimmune diseases. Its research is grounded in foundational microbiome science. The official website describes the company as developing treatments for difficult-to-treat conditions, leveraging world-class microbiome research. While specific historical milestones such as founding date, funding rounds, or pipeline events are not available in the provided evidence, the company is active in the biotechnology sector in South Korea. Its website includes sections on company introduction, research achievements, core technology, and recruitment, suggesting ongoing operations and research activities. The company is registered as a business entity in South Korea and is associated with Nam-gu.

Developer of microbiome-based therapeutics for intractable immune diseases

• Microbiome-targeted therapeutics

  Therapeutics for intractable immune diseases such as cancer and autoimmune diseases.

1. 1이뮤노바이옴 | ImmunoBiomeimmunobiome.co.kr
2. 2ImmunoBiome, Inc. (Korea) - Wikidatawikidata.org